ArticleAnti-cancer drugs2026

Comparative study of the efficacy and safety of PSOX and SOX plus sintilimab regimens as first-line treatments for advanced gastric cancer.

Tao Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.